In summary, LINCRIS regulates the ubiquitination of the crucial m6A reader protein IGF2BP2 and the LINRIS-IGF2BP2-MYC axis might be a promising therapeutic target of CRC. The gene discussed is IGF2BP2; the disease is colorectal carcinoma.